Tillotts Pharma: Positive Results of Largest Phase III Clinical Trial of Mesalazine Induction Therapy Published
11th October 2017
Rheinfelden, Switzerland
more »
Press releases
Champion der Gastroenterologie in Europa
Original German article and English translation available.
18th September 2015
Basler Zeitung
more »
Tillotts Pharma AG ist auf Expansionskurs
Original German article and English translation available.
2nd July 2015
Regio Aktuell
more »
Many Europeans with mild-to-moderate ulcerative colitis nonadherent to therapy
24th April 2015
Healio Gastroenterology
more »
Improving adherence to ulcerative colitis medications: an interview with Mattias Norrman, COO, Tillotts Pharma
17th March 2015
more »